- Patent expiration dates:
- August 11, 2028
✓
Drug substance
- Pharmaceutical composition
Patent 9,186,411
Issued: November 17, 2015
Inventor(s): Hiraishi Yasuhiro & Nonomura Muneo
Assignee(s): Takeda Pharmaceutical Company Limited
The present invention provides a pharmaceutical composition or a solid preparation containing a stabilized pharmaceutically active ingredient and a stabilizing method thereof.
Patent expiration dates:
- August 11, 2030
✓
Drug product
Related exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- November 1, 2026 - NEW PRODUCT
- May 3, 2027 - NEW CHEMICAL ENTITY